HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Putting the NHS England on trial: uncertainty-as-power, evidence and the controversy of PrEP in England.

Abstract
Pre-exposure prophylaxis (PrEP) (Truvada) is a medication which if taken correctly is almost entirely effective in preventing HIV infection. In regions and countries where it has been widely taken up, HIV seroconversion rates have significantly decreased. Alongside testing and treatment, it offers the very real prospect of ending HIV infections. However, in England, commissioning it has (and still is) a controversial process, where NHS England has repeatedly raised supposed 'uncertainties', first legal and then scientific. The same has not happened in Scotland, where PrEP was commissioned to anyone who needed it in April 2017. This article presents a close reading of the IMPACT trial protocol, which we conclude cannot answer the questions it sets out to answer. We then suggest that the uncertainties the trial claims to address are in fact a tool of power which is deployed to strategically ration healthcare; introduce uncertainty about commissioning PrEP; and shift the boundary between individual responsibilities and state responsibilities for public health and HIV prevention. We conclude that all the above constitute an unethical use of clinical trial rhetoric, systematically discriminate against minority and vulnerable groups, and ration healthcare for those who most need it. As such, we call on all academics, clinicians and activists to resist further unethical misuses of clinical trial rhetoric.
AuthorsMaurice Nagington, Tony Sandset
JournalMedical humanities (Med Humanit) Vol. 46 Issue 3 Pg. 176-179 (Sep 2020) ISSN: 1473-4265 [Electronic] United States
PMID32054770 (Publication Type: Journal Article)
Copyright© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Chemical References
  • Anti-HIV Agents
Topics
  • Anti-HIV Agents (therapeutic use)
  • Clinical Trials as Topic (ethics)
  • England
  • HIV Infections (prevention & control)
  • Humans
  • Pre-Exposure Prophylaxis (ethics)
  • Scotland
  • State Medicine (ethics)
  • Uncertainty

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: